Wednesday, December 12, 2012

Nanosphere Gets Yet Another FDA Approval

Nanosphere (NSPH) issued a press release on 02012.12.12 having the following headline: "Nanosphere Receives FDA Clearance for C. difficile Test". The press release contained the following quote by CEO Bill Moffitt. "With four new products cleared by the FDA in the last 12 months, we are pleased to lead the market in providing a comprehensive suite of tests that can improve patient outcomes and reduce healthcare spending."

NSPH closed yesterday (02012.12.11) at $2.79. 52-week range: $1.20 - $3.89.

No comments:

Post a Comment